Walter & Keenan Wealth Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-3,264
| Closed | -$259K | – | 158 |
|
|
2025
Q4 | $259K | Sell |
3,264
-800
| -20% | -$63.1K | 0.07% | 145 |
|
|
2025
Q3 | $306K | Sell |
4,064
-38
| -0.9% | -$2.6K | 0.09% | 131 |
|
|
2025
Q2 | $283K | Buy |
4,102
+415
| +11% | +$27.2K | 0.08% | 132 |
|
|
2025
Q1 | $250K | Buy |
+3,687
| New | +$221K | 0.08% | 136 |
|
|
2024
Q4 | – | Sell |
-3,322
| Closed | -$209K | – | 154 |
|
|
2024
Q3 | $209K | Buy |
+3,322
| New | +$194K | 0.06% | 145 |
|
|
2024
Q2 | – | Sell |
-3,450
| Closed | -$275K | – | 148 |
|
|
2024
Q1 | $275K | Sell |
3,450
-3,662
| -51% | -$280K | 0.09% | 122 |
|
|
2023
Q4 | $562K | Sell |
7,112
-945
| -12% | -$67.3K | 0.2% | 95 |
|
|
2023
Q3 | $563K | Sell |
8,057
-355
| -4% | -$25.2K | 0.22% | 93 |
|
|
2023
Q2 | $582K | Buy |
8,412
+5
| +0.1% | +$356 | 0.21% | 96 |
|
|
2023
Q1 | $625K | Sell |
8,407
-2,533
| -23% | -$212K | 0.24% | 89 |
|
|
2022
Q4 | $1.02M | Buy |
10,940
+450
| +4% | +$43.4K | 0.4% | 64 |
|
|
2022
Q3 | $1M | Buy |
10,490
+249
| +2% | +$24.6K | 0.42% | 61 |
|
|
2022
Q2 | $949K | Sell |
10,241
-300
| -3% | -$29.3K | 0.38% | 66 |
|
|
2022
Q1 | $1.07M | Hold |
10,541
| – | – | 0.36% | 65 |
|
|
2021
Q4 | $1.09M | Sell |
10,541
-4,800
| -31% | -$444K | 0.35% | 68 |
|
|
2021
Q3 | $1.3M | Sell |
15,341
-9,893
| -39% | -$829K | 0.44% | 61 |
|
|
2021
Q2 | $2.11M | Hold |
25,234
| – | – | 0.73% | 45 |
|
|
2021
Q1 | $1.9M | Buy |
25,234
+500
| +2% | +$36.4K | 0.67% | 50 |
|
|
2020
Q4 | $1.69M | Sell |
24,734
-10,100
| -29% | -$657K | 0.61% | 49 |
|
|
2020
Q3 | $2.03M | Buy |
34,834
+613
| +2% | +$38.1K | 0.81% | 40 |
|
|
2020
Q2 | $2.22M | Buy |
+34,221
| New | +$2.15M | 0.9% | 39 |
|
|
2020
Q1 | – | Sell |
-31,384
| Closed | -$2.33M | – | 133 |
|
|
2019
Q4 | $2.33M | Buy |
31,384
+1,200
| +4% | +$84.3K | 0.9% | 39 |
|
|
2019
Q3 | $1.9M | Buy |
30,184
+3,834
| +15% | +$227K | 0.72% | 43 |
|
|
2019
Q2 | $1.44M | Hold |
26,350
| – | – | 0.63% | 49 |
|
|
2019
Q1 | $1.42M | Buy |
26,350
+10,863
| +70% | +$670K | 0.63% | 46 |
|
|
2018
Q4 | $1.01M | Buy |
15,487
+2,637
| +21% | +$197K | 0.46% | 55 |
|
|
2018
Q3 | $1.01K | Buy |
12,850
+250
| +2% | +$17.9K | 0.3% | 65 |
|
|
2018
Q2 | $811K | Sell |
12,600
-1,580
| -11% | -$104K | 0.35% | 71 |
|
|
2018
Q1 | $882K | Sell |
14,180
-100
| -0.7% | -$7.17K | 0.38% | 66 |
|
|
2017
Q4 | $1.03M | Buy |
14,280
+680
| +5% | +$49.4K | 0.43% | 64 |
|
|
2017
Q3 | $1.11M | Buy |
13,600
+900
| +7% | +$71.2K | 0.51% | 62 |
|
|
2017
Q2 | $1.02M | Buy |
12,700
+250
| +2% | +$19.7K | 0.51% | 60 |
|
|
2017
Q1 | $977K | Buy |
12,450
+4,000
| +47% | +$319K | 0.51% | 59 |
|
|
2016
Q4 | $667K | Sell |
8,450
-9,000
| -52% | -$728K | 0.35% | 66 |
|
|
2016
Q3 | $1.55M | Sell |
17,450
-1,050
| -6% | -$99.1K | 0.86% | 41 |
|
|
2016
Q2 | $1.77M | Buy |
18,500
+2,550
| +16% | +$254K | 0.99% | 36 |
|
|
2016
Q1 | $1.65M | Buy |
15,950
+7,600
| +91% | +$739K | 0.95% | 35 |
|
|
2015
Q4 | $816K | Buy |
+8,350
| New | +$818K | 0.48% | 58 |
|
Other funds holding CVS
VCM
VPM
Walter & Keenan Wealth Management's CVS Position: Q1 2026 in Review
Walter & Keenan Wealth Management sold out of CVS Health (CVS) in Q1 2026, closing a stake of 3,264 shares — an estimated $259K sold.
Walter & Keenan Wealth Management first reported a position in CVS in Q4 2015 and held it in 38 quarters. The position peaked at $2.33M in Q4 2019. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Walter & Keenan Wealth Management reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
- Walter & Keenan Wealth Management sold 3,264 CVS Health shares in Q1 2026, an estimated $259K.
- Walter & Keenan Wealth Management first reported a position in CVS Health in Q4 2015 and held it in 38 quarters.
- Walter & Keenan Wealth Management's CVS Health position peaked at $2.33M in Q4 2019.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Walter & Keenan Wealth Management's 13F filing for Q1 2026, filed 11 May 2026.